If, as proposed, asthma is an IgE-associated bronchospastic disease attributable to acarian species, and SCGB1A1 has an anti-acarian role, then one would expect both low levels and mutations of SCGB1A1 to influence the development of the disease. This evidence concerns the gene IGHE and asthma.